Galmed Pharma (GLMD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts GLMD Hot Sheet
Join SI Premium – FREE
Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.38), in-line with the analyst estimate of ($0.38).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- JPMorgan Upgrades Tokyo Century (8439:JP) to Overweight
- JPMorgan Downgrades Rakuten Inc. (4755:JP) (RKUNF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
